Russell Investments Group
CTSO icon

Russell Investments Group’s Cytosorbents Corp CTSO Stock Holding History

Russell Investments Group’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-13,101
Closed -$98K – 3071
2021
Q2 		$98K Buy
+13,101
New +$110K ﹤0.01% 3059

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Russell Investments Group's CTSO Position: Q3 2021 in Review

Russell Investments Group sold out of Cytosorbents Corp (CTSO) in Q3 2021, closing a stake of 13,101 shares — an estimated $98K sold.

Russell Investments Group first reported a position in CTSO in Q2 2021 and held it in 1 quarter. The position peaked at $98K in Q2 2021. 96 funds tracked by Wall St. Rank hold CTSO as of Q3 2021.

  • Russell Investments Group reported no remaining Cytosorbents Corp position as of Q3 2021 after selling out during the quarter.
  • Russell Investments Group sold 13,101 Cytosorbents Corp shares in Q3 2021, an estimated $98K.
  • Russell Investments Group first reported a position in Cytosorbents Corp in Q2 2021 and held it in 1 quarter.
  • Russell Investments Group's Cytosorbents Corp position peaked at $98K in Q2 2021.
  • 96 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2021.

Based on Russell Investments Group's 13F filing for Q3 2021, filed 8 Nov 2021.